Itatani Y. et al. demonstrated that anti-VEGF therapy in VEGF-resistant CRC mouse models increases plasma G-CSF levels, which promotes neutrophil infiltration and enhances angiogenesis via upregulation of Bv8 in TANs. Here, PROK2 is linked to colorectal carcinoma.